Figure 3.
Type I IFN inhibits DEX-induced GILZ. (A) Daily prednisolone dose in SLE patients with low or high IFN score (GSE88884, n=1756). (B) GILZ expression in PBMC of SLE patients stratified by daily prednisolone dose (GSE88884, n=1756). (C, D) Healthy PBMC were treated with IFNα, DEX or both, after which GILZ mRNA expression was analysed by qPCR (C), and GILZ protein level was analysed by flow cytometry in the same samples (D) GILZ protein level is represented as MFI normalized against the control MFI for each donor. n=9, pooled from three independent experiments. *p<0.05, **p<0.01, ****p<0.0001. #symbol indicates significance of difference from control (untreated) cells, # p<0.05, ## p<0.01, ### p <0.001, ####p<0.0001.
